Hermetica Superfood Encyclopedia
The Short Answer
Calcium bisglycinate delivers elemental calcium chelated to two glycine molecules, enabling absorption via intestinal peptide transporter pathways (PepT1) rather than the pH-dependent passive diffusion required by inorganic salts, effectively shielding the calcium ion from inhibitory dietary ligands such as phytates and oxalates. Comparative bioavailability studies indicate approximately 44% fractional absorption—roughly 1.8 times greater than calcium citrate and superior to calcium carbonate—making it the highest-bioavailability oral calcium form currently documented.
CategoryMineral
GroupMineral
Evidence LevelPreliminary
Primary Keywordcalcium bisglycinate benefits
Calcium Bisglycinate — botanical close-up
Health Benefits
**Bone Mineral Density Support**
Elemental calcium delivered via bisglycinate directly supplies the primary mineral constituent of hydroxyapatite [Ca10(PO4)6(OH)2], the crystalline matrix of cortical and trabecular bone; superior fractional absorption (~44%) means more calcium reaches the osteoblast-rich remodeling front compared to carbonate or citrate forms.
**Osteoporosis and Fracture Risk Reduction**
By maintaining a positive calcium balance, bisglycinate supplementation supports suppression of parathyroid hormone (PTH)-driven osteoclastic resorption; adequate calcium intake combined with high bioavailability is associated with reduced bone turnover markers in postmenopausal populations.
**Calcium Deficiency Correction**
The chelated form is particularly effective in individuals with achlorhydria, elderly patients, or those on proton-pump inhibitors, because unlike calcium carbonate it does not require an acidic gastric environment to dissolve, allowing effective repletion regardless of gastric pH.
**Gastrointestinal Tolerability**
Bisglycinate's amino acid transport mechanism bypasses the luminal ionization step that can cause osmotic side effects; clinical observations and product-safety data indicate a gentler GI profile than carbonate, with lower rates of bloating and constipation at equivalent elemental doses.
**Food and Beverage Fortification Efficacy**
Calcium bisglycinate's 205-fold greater solubility versus calcium citrate, stable pH range (6.0–9.0), and minimal sensory impact make it suitable for fortifying dairy products, plant-based milks, cereals, and juices at 5–30 mg/100 g without altering texture, color, or flavor.
**Pregnancy and Lactation Support**
High bioavailability reduces the absolute amount required to meet the increased fetal skeletal mineralization demands of pregnancy (RDA ~1,000 mg elemental Ca/day); bisglycinate's gentle profile and amino acid carrier form make it a practical choice for prenatal supplementation.
**Muscle and Nerve Function**
Calcium ions modulate voltage-gated calcium channels, troponin C-mediated muscle contraction, and synaptic neurotransmitter release; sustained adequate calcium status supported by highly bioavailable bisglycinate helps maintain normal neuromuscular excitability and cardiovascular rhythmicity.
Origin & History
Natural habitat
Calcium bisglycinate is a fully synthetic chelated mineral compound with no geographic or botanical origin; it is manufactured through a controlled chelation process in which elemental calcium is chemically bonded to two glycine molecules (the simplest amino acid) in a 1:2 molar ratio. The compound (CAS 35947-07-0, molecular formula C4H8CaN2O4, molecular weight 188.20 g/mol) is produced industrially as a white to off-white powder under pharmaceutical or food-grade conditions, typically meeting USP or food-additive specifications. It has no history in traditional agriculture or wild harvesting, as it was developed in the modern nutraceutical and food-fortification era specifically to overcome the absorption limitations of inorganic calcium salts.
“Calcium bisglycinate has no history in traditional medicine, ethnobotany, or cultural healing practices; it is an entirely modern pharmaceutical-grade chelate developed in the latter half of the 20th century as part of the broader amino acid chelate mineral technology pioneered by researchers such as Harvey Ashmead at Albion Laboratories in the 1970s–1980s. The underlying principle—using amino acids as mineral carriers to improve bioavailability—was inspired by the observation that minerals naturally occurring in food are often bound to organic ligands and absorbed more efficiently than isolated inorganic salts. Regulatory recognition followed commercial development: calcium bisglycinate is now listed as a permitted food additive or novel food ingredient in multiple jurisdictions including the European Union (as calcium glycinate) and is classified as Generally Recognized As Safe (GRAS) for food fortification purposes in the United States. Its development context is therefore entirely nutraceutical and food-technology driven, with no counterpart in Ayurvedic, Traditional Chinese Medicine, or Western herbal traditions.”Traditional Medicine
Scientific Research
The evidence base for calcium bisglycinate is limited compared to calcium carbonate and citrate; large, prospective randomized controlled trials specifically using bisglycinate as the intervention and measuring hard endpoints such as bone mineral density (BMD) change or fracture incidence are lacking in the published literature. Comparative bioavailability data—including the frequently cited ~44% fractional absorption and 1.8-fold superiority over calcium citrate—derive primarily from earlier pharmacokinetic studies and textbook references (e.g., Groff & Gropper, 2000) rather than contemporary large-cohort RCTs with pre-registered protocols and rigorous blinding. A food-science study evaluating calcium bisglycinate fortification of kefir at 5–30 mg/100 g milk demonstrated preserved physicochemical parameters (pH, syneresis, sensory scores on a 1–9 scale) over 21 days of refrigerated storage, confirming technological feasibility, but this study was not designed to assess human health outcomes or provide sample-size-powered efficacy data. Overall, the evidence tier is moderate-preliminary: mechanistic and pharmacokinetic rationale is strong, food-safety data are supportive, but clinicians seeking bisglycinate-specific BMD or fracture data should recognize the current evidence gap and rely on class-level calcium supplementation literature until dedicated RCTs are published.
Preparation & Dosage
Traditional preparation
**Capsules/Tablets**
250–500 mg elemental calcium per serving (note: elemental calcium content is approximately 21% of bisglycinate salt weight by mass); typically taken 1–2 times daily with meals to co-activate intestinal transporters
**Powder (Bulk/Functional Food)**
5–30 mg elemental calcium per 100 g in dairy fortification
USP-grade white to off-white powder, pH 6.0–9.0 in solution; shelf life approximately 3 years stored at ≤20°C in sealed, moisture-controlled containers; used at .
**Liquid Supplements**
Dissolved in aqueous matrices for beverages or functional foods; high solubility (205× calcium citrate) allows clear or near-clear solutions at typical fortification concentrations.
**Standard Supplemental Dose**
200 mg elemental calcium daily in divided doses (≤500 mg per dose for optimal absorption kinetics); dosing above 500 mg per single administration does not proportionally increase fractional absorption
500–1,.
**Timing**
With food is preferred to stimulate bile and pancreatic secretions that facilitate enterocyte uptake; bisglycinate retains superiority over carbonate even in fasting/low-acid states, but food co-ingestion remains best practice.
**Fortification Level**
5–30 mg elemental calcium per 100 g dairy product demonstrated safe and organoleptically neutral in fermented milk studies; higher fortification levels require formulation-specific stability testing
**Standardization**
Commercial USP-grade bisglycinate is standardized to declared elemental calcium content verified by chelation or ICP-MS assay; reputable manufacturers provide certificates of analysis confirming heavy-metal absence.
Nutritional Profile
Calcium bisglycinate provides elemental calcium as its sole nutritionally active mineral, contributing approximately 210 mg elemental calcium per gram of bisglycinate salt (theoretical: Ca molecular weight 40.08 ÷ bisglycinate MW 188.20 ≈ 21.3% elemental calcium). The two glycine ligands per molecule (each ~75 g/mol) contribute negligible protein calories or amino acid load at typical supplemental doses (≤500 mg elemental Ca delivers <2 g glycine). No significant macronutrient, lipid, carbohydrate, vitamin, or phytochemical content is present; the compound is essentially a pure mineral chelate. Bioavailability factors strongly favor bisglycinate: the chelated structure resists precipitation by dietary phytates (found in grains, legumes) and oxalates (spinach, tea), and absorption is independent of gastric acid pH, distinguishing it from calcium carbonate which requires an acidic environment for dissolution. Fractional absorption of approximately 44% compares favorably to calcium citrate (~32–36%), calcium carbonate (~22–40% acid-dependent), and calcium gluconate (~27%).
How It Works
Mechanism of Action
Calcium bisglycinate is absorbed primarily through the intestinal peptide transporter PepT1 (SLC15A1) located on the apical brush-border membrane of enterocytes in the duodenum and proximal jejunum, a carrier-mediated pathway normally used for di- and tripeptides that is saturable but pH-independent, circumventing the ionization step required by inorganic salts. The glycine chelation sterically shields the calcium ion from forming insoluble complexes with dietary inhibitors—phytic acid, oxalic acid, and polyphenols—that would otherwise precipitate calcium in the intestinal lumen and block passive paracellular absorption. Once inside the enterocyte, the chelate is dissociated and calcium is shuttled across the basolateral membrane via the plasma membrane Ca²⁺-ATPase (PMCA1b) and the sodium–calcium exchanger (NCX1), entering portal circulation for delivery to bone, kidney, and soft tissues. At the cellular level, adequate intracellular calcium activates calmodulin-dependent kinases, supports osteoblast differentiation through Wnt/β-catenin signaling, and downregulates PTH secretion by activating the calcium-sensing receptor (CaSR) on parathyroid chief cells, collectively reducing osteoclastic bone resorption.
Clinical Evidence
No large Phase III randomized controlled trials have been published specifically investigating calcium bisglycinate as a named intervention for osteoporosis, fracture prevention, or bone mineral density, limiting direct clinical extrapolation. Comparative absorption studies position bisglycinate as the highest-bioavailability oral calcium salt (~44% fractional absorption versus ~32% for citrate and ~22–27% for carbonate in low-acid conditions), though these figures originate from small pharmacokinetic crossover designs rather than multicenter RCTs powered for clinical endpoints. The most specific applied study evaluated kefir fortification (5–30 mg elemental calcium per 100 g milk) and found no detrimental changes in acidity, syneresis, or consumer-rated sensory attributes over a 21-day shelf-life trial, confirming functional utility in food matrices without characterizing clinical outcomes. Confidence in the bioavailability advantage is moderate and mechanistically well-supported; confidence in downstream clinical benefits (fracture reduction, BMD preservation) is inferred from the broader calcium supplementation literature and requires bisglycinate-specific trial confirmation.
Safety & Interactions
At recommended supplemental doses (500–1,200 mg elemental calcium/day), calcium bisglycinate is considered well-tolerated; the chelated form produces fewer gastrointestinal complaints (constipation, bloating, gas) than calcium carbonate, and the MSDS classifies the bulk compound as low acute toxicity with no explosive or strongly flammable properties at ambient conditions. Hypercalcemia risk arises at total elemental calcium intakes substantially exceeding the tolerable upper intake level (UL: 2,000–2,500 mg/day for adults per the Institute of Medicine), manifesting as nausea, polyuria, nephrolithiasis, and soft-tissue calcification; bisglycinate's superior absorption theoretically warrants vigilance against inadvertent over-supplementation relative to lower-bioavailability forms. Drug interactions relevant to all calcium supplements include: reduced absorption of fluoroquinolone and tetracycline antibiotics (space doses by ≥2 hours), impaired absorption of bisphosphonates (alendronate, risedronate; take calcium ≥30 minutes after), potential antagonism of thyroid hormone (levothyroxine; separate by ≥4 hours), and additive hypercalcemia risk with thiazide diuretics and vitamin D megadosing. Calcium bisglycinate is considered appropriate for use in pregnancy and lactation given its favorable absorption profile, though total daily calcium from all dietary and supplemental sources should be tracked to remain within trimester-specific RDA (1,000 mg/day) and UL thresholds; individuals with a history of hypercalcemia, hyperparathyroidism, or calcium-containing kidney stones should use under medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ca(COOCH2NH2)2calcium diglycinatecalcium glycinatebis(glycinato)calciumCAS 35947-07-0
Frequently Asked Questions
Is calcium bisglycinate better absorbed than calcium carbonate or citrate?
Yes—calcium bisglycinate demonstrates approximately 44% fractional absorption, compared to roughly 32–36% for calcium citrate and 22–40% (acid-dependent) for calcium carbonate, making it the highest-bioavailability oral calcium form currently documented. Its chelated structure enables absorption via intestinal PepT1 peptide transporters independently of gastric acid pH, which is particularly advantageous for individuals with achlorhydria, elderly users, or those taking proton-pump inhibitors where carbonate absorption is severely compromised.
What is the recommended dosage of calcium bisglycinate per day?
Most supplements provide 250–500 mg of elemental calcium per serving, with a typical daily total of 500–1,200 mg elemental calcium divided into doses of no more than 500 mg at one time, because fractional absorption decreases at higher single doses. Total daily calcium from all dietary and supplemental sources should not exceed the Institute of Medicine tolerable upper intake level of 2,000–2,500 mg elemental calcium for adults to avoid hypercalcemia risk.
Does calcium bisglycinate cause constipation or stomach upset?
Calcium bisglycinate has a significantly gentler gastrointestinal profile than calcium carbonate; the amino acid transport mechanism bypasses the luminal acid-dissolution step that contributes to carbonate's constipation and bloating side effects. At standard supplemental doses, bisglycinate is generally well-tolerated, though exceeding the tolerable upper intake level for total calcium (>2,000–2,500 mg elemental/day) from all sources can cause nausea, constipation, and in severe cases hypercalcemia.
Can calcium bisglycinate be taken with other medications?
Calcium bisglycinate shares interaction risks common to all calcium supplements: it can reduce absorption of fluoroquinolone and tetracycline antibiotics, bisphosphonates (e.g., alendronate), and levothyroxine if taken simultaneously, so these medications should be spaced at least 2–4 hours apart from calcium doses. Thiazide diuretics (e.g., hydrochlorothiazide) reduce urinary calcium excretion and when combined with supplemental calcium can increase hypercalcemia risk; individuals on these medications should consult a healthcare provider before supplementing.
Is calcium bisglycinate safe during pregnancy?
Calcium bisglycinate is considered appropriate for use during pregnancy due to its high bioavailability (~44% fractional absorption), which helps meet the increased demand for fetal skeletal mineralization without requiring very large doses, and its gentle gastrointestinal profile suits the GI sensitivity common in pregnancy. The recommended dietary allowance for calcium during pregnancy remains 1,000 mg elemental calcium per day for adults, and total intake from diet plus supplementation should stay below the 2,500 mg/day tolerable upper intake level; prenatal supplementation should always be coordinated with an obstetrician or registered dietitian.
What is the difference between calcium bisglycinate and other chelated calcium forms?
Calcium bisglycinate is a chelated form where calcium is bound to two glycine amino acids, creating a stable complex that enhances intestinal absorption without requiring stomach acid for dissolution. Unlike other chelated forms such as calcium malate or calcium citrate malate, bisglycinate specifically leverages glycine's role as an inhibitory neurotransmitter, potentially offering mild calming benefits alongside mineral delivery. The bisglycinate chelation also tends to have a neutral pH and minimal impact on stomach acid, making it gentler on the GI tract compared to ionic calcium salts.
Who should prioritize calcium bisglycinate supplementation over other calcium forms?
Individuals with compromised gastric acid production (including those on proton pump inhibitors), sensitive digestive systems, or those seeking enhanced bioavailability without gastrointestinal burden are ideal candidates for calcium bisglycinate. Older adults and postmenopausal women experiencing accelerated bone loss also benefit from the superior fractional absorption (~44%) that bisglycinate provides, ensuring maximum mineral delivery to bone remodeling sites. Athletes and active individuals may benefit from the glycine co-ligand's potential role in collagen synthesis and joint support alongside bone mineralization.
How does calcium bisglycinate absorption compare to getting calcium from food sources?
While dietary calcium from sources like dairy, leafy greens, and fortified foods provides bioavailable calcium, it often requires adequate stomach acid and is subject to inhibitors like phytates and oxalates that reduce net absorption. Calcium bisglycinate bypasses many of these dietary absorption barriers through chelation, delivering a more consistent and predictable absorption rate (~44%) regardless of stomach acid levels or meal composition. For individuals unable to consume sufficient dietary calcium (due to lactose intolerance, plant-based diets, or malabsorption conditions), bisglycinate supplementation ensures reliable mineral intake to meet bone health requirements.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w calcium-bisglycinate curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
